The dermatological market remains highly competitive, with increasing investment by big pharmaceutical and specialty biotech firms. With current worldwide revenues of $20bn, the area remains arguably the most lucrative of all pharmaceutical sectors today. New treatments and increasing disease prevalence will drive significant area expansion over the next 15 years.Focusing on advances in drug delivery, skin treatments and anti-ageing products, join Visiongain’s Dermatological Advances 2010 conference to learn more about the advances pushing this dynamic area forward. This senior networking event will empower your strategies to develop and refine products in this highly exciting market sector.